These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944 [TBL] [Abstract][Full Text] [Related]
23. FDA notifications. Rare complication with didanosine. AIDS Alert; 2010 Apr; 25(4):46-8. PubMed ID: 20560192 [No Abstract] [Full Text] [Related]
24. FDA advisory on nevirapine. AIDS Treat News; 2005 Jan; (409):7. PubMed ID: 15791716 [TBL] [Abstract][Full Text] [Related]
25. FDA notifications. FDA approves generic stavudine. AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156 [No Abstract] [Full Text] [Related]
26. FDA notifications. FDA approved 3 generic formulations of stavudine. AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951 [No Abstract] [Full Text] [Related]
30. FDA notifications. Revised guidelines for pregnant women. AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483 [No Abstract] [Full Text] [Related]
31. Tenofovir drug interactions: ddI and d4T. TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363 [No Abstract] [Full Text] [Related]
32. FDA notifications. Generic didanosine approved by FDA. AIDS Alert; 2008 Nov; 23(11):127-8. PubMed ID: 19043869 [No Abstract] [Full Text] [Related]
33. Incidence of acute pancreatitis and nucleoside reverse transcriptase inhibitors usage. Dragovic G; Milic N; Jevtovic DJ Int J STD AIDS; 2005 Jun; 16(6):427-9. PubMed ID: 15969777 [TBL] [Abstract][Full Text] [Related]
34. FDA notifications. Tentative approval granted for lamivudine/stavudine. AIDS Alert; 2008 Aug; 23(8):92-3. PubMed ID: 18727174 [No Abstract] [Full Text] [Related]
35. Extended warning on Didanosine-related pancreatitis. Res Initiat Treat Action; 1999 Dec; 5(5):22-3. PubMed ID: 11366889 [TBL] [Abstract][Full Text] [Related]
36. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination. Skopelitis EE; Kokotis PI; Kontos AN; Panayiotakopoulos GD; Konstantinou K; Kordossis T; Karandreas N Int J STD AIDS; 2006 Jul; 17(7):467-72. PubMed ID: 16820077 [TBL] [Abstract][Full Text] [Related]
37. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection. Cepeda JA; Wilks D AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516 [No Abstract] [Full Text] [Related]
38. New uses for tenofovir: more questions about d4T. Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676 [TBL] [Abstract][Full Text] [Related]
39. Fatal lactic acidosis during antiretroviral therapy. Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648 [TBL] [Abstract][Full Text] [Related]
40. Recent developments in HIV research. Boyle BA AIDS Read; 2002 Sep; 12(9):390-4, 407. PubMed ID: 12402802 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]